Tanaka Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-115
Closed -$20K 50
2017
Q2
$20K Sell
115
-3,243
-97% -$527K 0.05% 41
2017
Q1
$551K Sell
3,358
-381
-10% -$63.3K 1.21% 27
2016
Q4
$547K Buy
3,739
+386
+12% +$58.1K 1.28% 26
2016
Q3
$559K Sell
3,353
-15
-0.4% -$2.54K 1.34% 23
2016
Q2
$512K Sell
3,368
-50
-1% -$7.77K 1.32% 23
2016
Q1
$512K Sell
3,418
-1,800
-34% -$267K 1.15% 25
2015
Q4
$847K Buy
5,218
+922
+21% +$145K 1.82% 21
2015
Q3
$594K Hold
4,296
1.5% 20
2015
Q2
$660K Hold
4,296
1.64% 21
2015
Q1
$687K Buy
4,296
+26
+0.6% +$4.09K 1.9% 17
2014
Q4
$680K Buy
+4,270
New +$665K 2.02% 19

Other funds holding AMGN

Tanaka Capital Management's AMGN Position: Q3 2017 in Review

Tanaka Capital Management sold out of Amgen (AMGN) in Q3 2017, closing a stake of 115 shares — an estimated $20K sold.

Tanaka Capital Management first reported a position in AMGN in Q4 2014 and held it in 11 quarters. The position peaked at $847K in Q4 2015. 1,606 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Tanaka Capital Management reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Tanaka Capital Management sold 115 Amgen shares in Q3 2017, an estimated $20K.
  • Tanaka Capital Management first reported a position in Amgen in Q4 2014 and held it in 11 quarters.
  • Tanaka Capital Management's Amgen position peaked at $847K in Q4 2015.
  • 1,606 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Tanaka Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.